Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
about
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent modelsGriffithsin: An Antiviral Lectin with Outstanding Therapeutic PotentialA novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitroChimeric Cyanovirin-MPER recombinantly engineered proteins cause cell-free virolysis of HIV-1.Enhanced potency of bivalent small molecule gp41 inhibitors.Highly potent chimeric inhibitors targeting two steps of HIV cell entrySelection of HBV preS1-binding penta-peptides by phage display.The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses.Structure-activity relationship studies of indole-based compounds as small molecule HIV-1 fusion inhibitors targeting glycoprotein 41.A novel gene therapy strategy using secreted multifunctional anti-HIV proteins to confer protection to gene-modified and unmodified target cells.Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41.The Effect of N-Terminal Cyclization on the Function of the HIV Entry Inhibitor 5P12-RANTES.HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
P2860
Q24610025-FE7DF840-35C8-4086-9281-C5A16CA0E6C3Q27928014-A4D0B437-38EF-4E43-946D-23E82E4A8184Q28728917-2D71E14F-E676-461F-8BC0-19BD29ED878AQ30352110-0B650594-6F42-4C1B-82F0-398E20800F2BQ34546445-53185880-345D-4C1B-A29F-55F16B45288FQ35150195-E94F8CD0-B461-49DC-9478-31026FD328F1Q35195132-48E27BF1-A7B5-4310-9290-40705AC3414EQ36327928-3C1F98E6-5AD3-4FEF-8ED3-F2831C5F9F3BQ37450191-3BB18F79-0287-4E9C-A249-C7A1B022D543Q38992313-425A058E-5852-46FA-A32C-46B048FE5C31Q39048904-3806A3A3-6F42-4C7D-A124-54AE79393658Q39471914-3EAF7752-D8F8-4ECE-A97C-A00386670C54Q40115327-3CE5A988-4B0D-440D-8472-70C1CE4F1249Q58555325-322F0B27-7E12-4A2F-BAAC-7FF34FCADF49
P2860
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@ast
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@en
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@nl
type
label
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@ast
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@en
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@nl
prefLabel
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@ast
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@en
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@nl
P2093
P2860
P356
P1476
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
@en
P2093
Arbi Gharibi
Beth A Snyder
Ioannis Kagiampakis
Kristabelle Alatas
Marie K Mankowski
Patricia J LiWang
Roger G Ptak
P2860
P304
P356
10.1128/AAC.00376-10
P407
P577
2010-10-18T00:00:00Z